228 related articles for article (PubMed ID: 8564089)
1. Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma.
Lock SH; Kay AB; Barnes NC
Am J Respir Crit Care Med; 1996 Feb; 153(2):509-14. PubMed ID: 8564089
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
Medley H; Orozco S; Allen A
Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
[TBL] [Abstract][Full Text] [Related]
3. Doubling daily inhaled corticosteroid dose is ineffective in mild to moderately severe attacks of asthma in adults.
Rice-McDonald G; Bowler S; Staines G; Mitchell C
Intern Med J; 2005 Dec; 35(12):693-8. PubMed ID: 16313543
[TBL] [Abstract][Full Text] [Related]
4. Comparison of a short course of prednisolone with sustained-release theophylline in the control of nocturnal asthma.
Chhabra SK
Indian J Chest Dis Allied Sci; 1995; 37(1):7-14. PubMed ID: 16892732
[TBL] [Abstract][Full Text] [Related]
5. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group.
Boyd G
Eur Respir J; 1995 Sep; 8(9):1494-8. PubMed ID: 8575574
[TBL] [Abstract][Full Text] [Related]
6. Trial of cyclosporin in corticosteroid-dependent chronic severe asthma.
Alexander AG; Barnes NC; Kay AB
Lancet; 1992 Feb; 339(8789):324-8. PubMed ID: 1346410
[TBL] [Abstract][Full Text] [Related]
7. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
[TBL] [Abstract][Full Text] [Related]
8. A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis.
Hingorani M; Moodaley L; Calder VL; Buckley RJ; Lightman S
Ophthalmology; 1998 Sep; 105(9):1715-20. PubMed ID: 9754182
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate therapy of oral corticosteroid-dependent asthmatics reduces serum immunoglobulins: correlation with clinical response to therapy.
Corrigan CJ; Shiner RJ; Shakur BH; Ind PW
Clin Exp Allergy; 2005 May; 35(5):579-84. PubMed ID: 15898978
[TBL] [Abstract][Full Text] [Related]
10. Heart rate-lowering efficacy and respiratory safety of ivabradine in patients with obstructive airway disease: a randomized, double-blind, placebo-controlled, crossover study.
Majewski S; Slomka S; Zielinska-Wyderkiewicz E; Ciebiada M; Gorski P
Am J Cardiovasc Drugs; 2012 Jun; 12(3):179-88. PubMed ID: 22409211
[TBL] [Abstract][Full Text] [Related]
11. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma.
Karpel JP; Nayak A; Lumry W; Craig TJ; Kerwin E; Fish JE; Lutsky B
Respir Med; 2007 Mar; 101(3):628-37. PubMed ID: 16875813
[TBL] [Abstract][Full Text] [Related]
12. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
[TBL] [Abstract][Full Text] [Related]
13. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
[TBL] [Abstract][Full Text] [Related]
14. The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation.
Djukanović R; Homeyard S; Gratziou C; Madden J; Walls A; Montefort S; Peroni D; Polosa R; Holgate S; Howarth P
Am J Respir Crit Care Med; 1997 Mar; 155(3):826-32. PubMed ID: 9117012
[TBL] [Abstract][Full Text] [Related]
15. The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma.
Spence DP; Johnston SL; Calverley PM; Dhillon P; Higgins C; Ramhamadany E; Turner S; Winning A; Winter J; Holgate ST
Am J Respir Crit Care Med; 1994 May; 149(5):1142-8. PubMed ID: 8173754
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of formoterol Turbuhaler when added to inhaled corticosteroid treatment in children with asthma.
Zimmerman B; D'Urzo A; Bérubé D
Pediatr Pulmonol; 2004 Feb; 37(2):122-7. PubMed ID: 14730657
[TBL] [Abstract][Full Text] [Related]
17. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids.
Crompton GK; Ayres JG; Basran G; Schiraldi G; Brusasco V; Eivindson A; Jamieson AH; Olsson H
Am J Respir Crit Care Med; 1999 Mar; 159(3):824-8. PubMed ID: 10051257
[TBL] [Abstract][Full Text] [Related]
18. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
Pauwels RA; Löfdahl CG; Postma DS; Tattersfield AE; O'Byrne P; Barnes PJ; Ullman A
N Engl J Med; 1997 Nov; 337(20):1405-11. PubMed ID: 9358137
[TBL] [Abstract][Full Text] [Related]
19. Potential masking effects of salmeterol on airway inflammation in asthma.
Mcivor RA; Pizzichini E; Turner MO; Hussack P; Hargreave FE; Sears MR
Am J Respir Crit Care Med; 1998 Sep; 158(3):924-30. PubMed ID: 9731027
[TBL] [Abstract][Full Text] [Related]
20. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
